Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
CervoMed (CRVO)
NASDAQ:CRVO
CervoMed (CRVO) Stock Price & Analysis
722 Followers
CRVO Stock Chart & Stats
Day’s Range$23.82 - $25.5
52-Week Range― - ―
Previous Close$24.99
Volume31.02K
Average Volume (3M)N/A
Market Cap
$196.60M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Apr 01, 2024EPS Estimate
-$0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$65.00Price Target Upside172.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
CervoMed News
PremiumCompany Announcements
CervoMed Updates Stakeholders on Clinical and Financial Status
PremiumCompany Announcements
CervoMed Shares Operational and Financial Insights Online
PremiumCompany Announcements
CervoMed’s Strategic $50 Million Private Placement DealRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CRVO FAQ
What was CervoMed’s price range in the past 12 months?
Currently, no data Available
What is CervoMed’s market cap?
Currently, no data Available
When is CervoMed’s upcoming earnings report date?
CervoMed’s upcoming earnings report date is Apr 01, 2024 which is 28 days ago.
How were CervoMed’s earnings last quarter?
CervoMed released its earnings results on Nov 13, 2023. The company reported -$0.7 earnings per share for the quarter, beating the consensus estimate of -$0.95 by $0.25.
Is CervoMed overvalued?
According to Wall Street analysts CervoMed’s price is currently Undervalued.
Does CervoMed pay dividends?
CervoMed does not currently pay dividends.
What is CervoMed’s EPS estimate?
CervoMed’s EPS estimate is -$0.39.
How many shares outstanding does CervoMed have?
Currently, no data Available
What happened to CervoMed’s price movement after its last earnings report?
CervoMed reported an EPS of -$0.7 in its last earnings report, beating expectations of -$0.95. Following the earnings report the stock price went down -2.575%.
Which hedge fund is a major shareholder of CervoMed?
Currently, no hedge funds are holding shares in CRVO
---
CervoMed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
318.99%
12-Months-Change
Fundamentals
Return on Equity
-46.51%
Trailing 12-Months
Asset Growth
-55.94%
Trailing 12-Months
Company Description
CervoMed
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages lead product candidate, transcrocetinate sodium, also known as trans sodium crocetinate, for use in those life threatening conditions in which cellular oxygen deprivation is the basis for significant unmet medical needs. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
---
CRVO Stock 12 Months Forecast
Average Price Target
$65.00
▲(172.88% Upside)
Technical Analysis
Best Analysts Covering CRVO
1 Year
1 Year Success Rate
2/2 ratings generated profit
1 Year Average Return
+45.35%
reiterated a buy rating 24 days ago
Copying Sumant Kulkarni's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +45.35% per trade.
---